Literature DB >> 35368828

The Relationship between APOL1 Structure and Function: Clinical Implications.

Sethu M Madhavan1, Matthias Buck2.   

Abstract

Common variants in the APOL1 gene are associated with an increased risk of nondiabetic kidney disease in individuals of African ancestry. Mechanisms by which APOL1 variants mediate kidney disease pathogenesis are not well understood. Amino acid changes resulting from the kidney disease-associated APOL1 variants alter the three-dimensional structure and conformational dynamics of the C-terminal α-helical domain of the protein, which can rationalize the functional consequences. Understanding the three-dimensional structure of the protein, with and without the risk variants, can provide insights into the pathogenesis of kidney diseases mediated by APOL1 variants.
Copyright © 2021 by the American Society of Nephrology.

Entities:  

Keywords:  APOL1; amino acids; apolipoprotein L1; chronic kidney disease; genetics; human APOL1 protein; kidney diseases; protein structure

Mesh:

Substances:

Year:  2020        PMID: 35368828      PMCID: PMC8785724          DOI: 10.34067/KID.0002482020

Source DB:  PubMed          Journal:  Kidney360        ISSN: 2641-7650


  71 in total

1.  Association of trypanolytic ApoL1 variants with kidney disease in African Americans.

Authors:  Giulio Genovese; David J Friedman; Michael D Ross; Laurence Lecordier; Pierrick Uzureau; Barry I Freedman; Donald W Bowden; Carl D Langefeld; Taras K Oleksyk; Andrea L Uscinski Knob; Andrea J Bernhardy; Pamela J Hicks; George W Nelson; Benoit Vanhollebeke; Cheryl A Winkler; Jeffrey B Kopp; Etienne Pays; Martin R Pollak
Journal:  Science       Date:  2010-07-15       Impact factor: 47.728

2.  The innate immune factor apolipoprotein L1 restricts HIV-1 infection.

Authors:  Harry E Taylor; Atanu K Khatua; Waldemar Popik
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

3.  Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of apolipoprotein L.

Authors:  P N Duchateau; C R Pullinger; R E Orellana; S T Kunitake; J Naya-Vigne; P M O'Connor; M J Malloy; J P Kane
Journal:  J Biol Chem       Date:  1997-10-10       Impact factor: 5.157

4.  The high resolution crystal structure of deoxyhemoglobin S.

Authors:  D J Harrington; K Adachi; W E Royer
Journal:  J Mol Biol       Date:  1997-09-26       Impact factor: 5.469

5.  The apolipoprotein L gene cluster has emerged recently in evolution and is expressed in human vascular tissue.

Authors:  Houshang Monajemi; Ruud D Fontijn; Hans Pannekoek; Anton J G Horrevoets
Journal:  Genomics       Date:  2002-04       Impact factor: 5.736

6.  Plasma apolipoprotein L1 levels do not correlate with CKD.

Authors:  Leslie A Bruggeman; John F O'Toole; Michael D Ross; Sethu M Madhavan; Marlene Smurzynski; Kunling Wu; Ronald J Bosch; Samir Gupta; Martin R Pollak; John R Sedor; Robert C Kalayjian
Journal:  J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 10.121

7.  Structure of human oxyhaemoglobin at 2.1 A resolution.

Authors:  B Shaanan
Journal:  J Mol Biol       Date:  1983-11-25       Impact factor: 5.469

8.  Alterations in plasma membrane ion channel structures stimulate NLRP3 inflammasome activation in APOL1 risk milieu.

Authors:  Alok Jha; Vinod Kumar; Shabirul Haque; Kamesh Ayasolla; Shourav Saha; Xiqian Lan; Ashwani Malhotra; Moin A Saleem; Karl Skorecki; Pravin C Singhal
Journal:  FEBS J       Date:  2019-12-02       Impact factor: 5.542

Review 9.  The molecular arms race between African trypanosomes and humans.

Authors:  Etienne Pays; Benoit Vanhollebeke; Pierrick Uzureau; Laurence Lecordier; David Pérez-Morga
Journal:  Nat Rev Microbiol       Date:  2014-06-30       Impact factor: 60.633

10.  To flip or not to flip: lipid-protein charge interactions are a determinant of final membrane protein topology.

Authors:  Mikhail Bogdanov; Jun Xie; Phil Heacock; William Dowhan
Journal:  J Cell Biol       Date:  2008-09-08       Impact factor: 10.539

View more
  1 in total

1.  APOL1 genotyping via buccal mucosa cell samples to establish risk of kidney disease.

Authors:  Dona Jeanne Alladagbin; Carlos Gustavo Regis da Silva; Luciano Kalabric Silva; Washington Lc Dos-Santos; Geraldo Gileno de Sá Oliveira
Journal:  BMC Nephrol       Date:  2022-10-10       Impact factor: 2.585

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.